AzTrials
AzTrials

Gastrointestinal HormonesNCT04249609

Composition of Meals Around Exercise Session

A study testing HCHO meals and exercise and LCHO meals and exercise in people with Gastrointestinal Hormones, run by University of Glasgow at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This will be a randomised cross-over study where participants will be asked to undergo screening session followed by submaximal exercise test and then undergo 2 experimental trials, one high CHO trial and another high fat trial, each lasting over 2 days. Read more about this study

Who is it for?
Ages 25 to 35 years, men onlyHealthy volunteers can take part
Conditions the study is for
Gastrointestinal Hormones
What is being tested?
HCHO meals and exercise and LCHO meals and exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 siteUnited Kingdom
Study dates
23 Apr 2019to 5 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 35 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy sedentary males aged between 25-35 years with body mass index (BMI) 25- 30 kg/m2
  • participants with stable body weight for at least 3 months.

Who cannot join

  • Smokers, suffering from food allergy, on any dietary supplements or dietary regimes at the time of the study
  • Participants with systolic/diastolic <90/60 mmHg and >140/90 mmHg or with history of chronic illness.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Human Nutrition, College of Medicine, Veterinary and Life Science

    Glasgow, G31 2ER

Other trials in United Kingdom

About this study

Official title: The Effect of Macronutrient Composition of Meals Consumed Around a Single Exercise Session of Subjective Appetite, Appetite Hormones and Daily Energy Intake in Overweight Men

This will be a randomised cross-over study where participants will be asked to undergo screening session followed by submaximal exercise test and then undergo 2 experimental trials, one high CHO trial and another high fat trial, each lasting over 2 days. On Day 1 participants will consume either high CHO or high fat evening meal and on Day 2 they will be exercising for 60 minutes in the fasted state and then consume either high CHO or high fat morning meal and then 5 hours after morning meal ad libitum buffet meal. After this, they will leave metabolic investigation room and will record all food and drinks consumed during the rest of the day. The washout period between the trials will be at least 7 days. Prior to each of the experimental trials, participants will be asked to avoid consumption of coffee and alcohol for the duration of 2 days. All data collection will all take place in the metabolic research unit at New Lister Building (NLB), Glasgow Royal infirmary (GRI).

Read the detailed description

The researcher will enrol eligible participants by means of an advertisement leaflet and word of mouth in the campus of the University of Glasgow and other major public areas. Those who show interest about the study will be contacted by the researcher who will explain the study in detail and will give them a copy of the participant information leaflet. If the participant is happy to participate, he will sign an informed consent form and privacy notes. Only participants with stable body weight for at least 3 months will be recruited and we will exclude those who are on positive or negative energy balance (recent weight gain or loss, ±2 kg the past month).

As part of the screening process, each participant will be asked to fill in Physical Activity Readiness Questionnaire (PARQ) and Health Screening Questionnaire. Only those who answered "no" to all questions in PARQ and were in generally good health will carry on with other aspects of the study. These questionnaires will be completed during screening session, which will take place at NLB, GRI. Height and body weigh will be measured at the screening session. Only those with BMI between 25.0-30 kg/m2 will be invited to participate. Smokers will not be recruited. It will be explained that their participation is voluntary, that they may withdraw at any point if they wish, and that the data collected will be anonymised. We will thank those subjects who have expressed an interest about the study but do not qualify and we will explain to them why they need to be excluded. Those who are eligible to participate will be enrolled in the trial which will last for 4 weeks and we will measure their height and weight.

Main Experimental Trials:

The experimental trials will last over 2 days. On day 1 Participants will consume provided dinner and on Day2 attend the metabolic research unit at New Lister Building of the Royal Infirmary in the fasted state at approximately 09:00 am. An intravenous cannula will be placed by a trained phlebotomist upon arrival. This will be used to draw blood samples throughout trial. After the collection of the first blood sample, the participant will walk on the treadmill at speed and grade corresponding to 55% of their maximal oxygen consumption. During exercise, participants will be wearing a heart rate monitor and a face mask connected to indirect calorimetry equipment to allow measurements of fat and CHO oxidation Ratings of perceived exertion will be recorded at every 10 minutes. Following exercise, participants will rest for 60 minutes and then either high CHO or high fat morning meal will be provided. Further blood samples will be collected for the duration of 5-hours; in total no more than 70 ml of blood will be taken during each of the trials. Following the last blood sample collection, participants will eat from ad libitum buffet and then leave laboratory and during the rest of the day will be recording all food and drink consumed.

Meal On day 1 dinner meal will provided with either high carbohydrate or high fat meal which contains 35% of participants total daily energy intakes. In high CHO trial, meal will consist of pasta, meat ball and orange juice. In high fat trial, meals will be based on burger, cheese, mushroom, nuts, and butter. On the day 2 and after 60 minutes exercise, participants will consume morning meal, providing 30% of their total daily energy intake. In high fat trial, morning meals will be based on white bread, peanut butter, nuts, and olives. In high CHO trial, meal will consist of oats, skimmed milk, banana and seedless raisins.

Exercise Tests Participants will conduct a submaximal exercise test to estimate their maximal oxygen consumption (V̇O2 max), a marker of cardiorespiratory fitness. During the main experimental trials, participants will undergo a 60-minute walking exercise at a predetermined work rate corresponding to 55% of their predicted V̇O2 max. Both exercise sessions will be conducted on a treadmill and will be at intensity below 85% of maximal HR. Heart rate and ratings of perceived exertion will be recorded throughout the test via a heart rate monitor.

Preparation for experimental trials Participants will be asked to record dietary intake for 2 days prior to the first experimental trial and will be asked to replicate this in the 2 days prior to the second experimental trial. Prior to both experimental trials participants will be asked to avoid consumption of coffee and alcohol for the duration of 3 days.

Being tested
HCHO meals and exercise, LCHO meals and exercise
Keywords
Exercise, Appetite, Gastrointestinal hormones, Macronutrient, Fat oxidation, Thermic effect of food, Energy intake
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HCHO meals and exerciseOther

    Also called High carbohydrate meals and exercise

    Exercise will be conducted after high carbohydrate dinner and prior to high carbohydrate breakfast

  • LCHO meals and exerciseOther

    Also called Low Carbohydrate and exercise Intervention

    Exercise will be conducted after high fat dinner and prior to high fat breakfast

Study groups in NCT04249609
Study groupRoleWhat they receive
High Carbohydrate Meals Around ExerciseExperimentalOn day 1, high CHO dinner meal will provide 35% of participants total daily energy requirements. Meal will consist of pasta, meat ball and orange juice. On the day 2, participants will exercise for 60 minutes and then in 60 minutes will consume morning meal, providing 30% of their total daily energy requirements. Morning meal will consist of oats, skimmed-milk, banana and seedless raisins.
Receives: Other: HCHO meals and exercise
Low Carbohydrate Meals Around ExerciseExperimentalOn day 1, low CHO dinner meal will provide 35% of participants total daily energy requirements. Meal will based on burger, cheese, mushroom, nuts, and butter.On the day 2, participants will exercise fro 60 minutes and then in 60 will consume morning meal, providing 30% of their total daily energy requirements. Meal will consist of white bread, egg, cheese, olive oil, nuts, and olives.
Receives: Other: LCHO meals and exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Appetite Hormones: Glucagon like peptide (GLP-1)

    Plasma concentration during HCHO and LCHO trials

    Measured: 420 minutes through study completion, an average of 10 days

  2. Appetite Hormone: Peptide YY (PYY)

    Plasma concentration during HCHO and LCHO trials

    Measured: 420 minutes through study completion, an average of 10 days

  3. Growth Differentiation Factor-15 (GDF 15)

    Plasma concentration during HCHO and LCHO trials

    Measured: 420 minutes through study completion, an average of 10 days

Secondary outcomes (7)
  1. Insulin

    Plasma concentration during HCHO and LCHO trials

    Measured: 420 minutes through study completion, an average of 10 days

  2. Glucose

    Plasma concentration during HCHO and LCHO trials

    Measured: 420 minutes through study completion, an average of 10 days

  3. Triglycerides

    Plasma concentration during HCHO and LCHO trials

    Measured: 420 minutes through study completion, an average of 10 days

  4. Subjective appetite scores

    Appetite scores during HCHO and LCHO trials will be assessed using a 100-mm Visual Analog Scale, with 0 mm meaning one and 100 mm another extreme of hunger, desire to eat, fullness, prospective food consumption, and satiety.

    Measured: 420 minutes through study completion, an average of 10 days

  5. Diet induced thermogenesis

    Metabolic rate measured during HCHO and LCHO trials by means of indirect calorimetry

    Measured: 420 minutes through study completion, an average of 10 days

  6. Dietary intake

    Energy and macronutrient intake during HCHO and LCHO trial will analyses using WinDiets software based on food composition tables.

    Measured: 24 hr through study completion, an average of 10 days

  7. Energy substrate oxidation

    Rate of carbohydrate and fat oxidation during HCHO and LCHO trials by means of indirect calorimetry

    Measured: 420 minutes through study completion, an average of 10 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jan 2020
  2. Study start23 Apr 2019
  3. Primary completion2 Jun 2022
  4. Study completion5 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
14 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04249609
Sponsor's protocol ID
200180122
Status last verified
Jul 2023
First submitted
1 Nov 2019
Last updated
1 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing HCHO meals and exercise and LCHO meals and exercise in people with Gastrointestinal Hormones, run by University of Glasgow at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Appetite Hormones: Glucagon like peptide (GLP-1) (time frame: 420 minutes through study completion, an average of 10 days). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in